May 23, 2025, Changsha – The 19th Annual Conference of the Chinese Medical Association’s Critical Care Medicine Division concluded successfully in Changsha. As a pioneering leader in respiratory therapy, Respircare captivated attendees with its five core products and comprehensive respiratory care solutions, emerging as a highlight of the event.

 

 

Innovative Product Portfolio Leading Industry Advancement

 

During the conference, Respircare showcased its independently developed respiratory therapy product series:

 

• BPAP DP Series Non-Invasive Ventilator

 

Featuring intelligent dynamic pressure compensation technology, it precisely addresses complex clinical needs such as acute respiratory failure and acute exacerbations of COPD. The device dynamically adjusts pressure output based on real-time patient breathing patterns, ensuring optimal respiratory support across all phases.

 

• BPAP V Series Positive Airway Pressure Therapy Device

 

Equipped with adaptive bi-level pressure technology, it significantly enhances patient-ventilator synchrony in COPD patients. By intelligently monitoring respiratory rhythms and automatically adjusting inspiratory and expiratory pressures, it minimizes asynchrony and improves treatment compliance.

 

• HUMID B Series High-Flow Respiratory Humidification Therapy System

 

Clinically validated in over 100,000 cases, its precise temperature and humidity control technology effectively reduces airway mucosal injury risk. The system ensures consistently optimal gas conditions, providing robust airway protection.

 

• BPAP H Series Non-Invasive High-Flow Integrated System

 

Offering multi-mode seamless switching, it supports step-down therapy from ICU to general wards. The device ensures continuity and stability in respiratory support across different treatment phases.

 

• Respiratory Humidifier Series

 

Featuring multiple modes and precise humidification, it caters to diverse patient needs. With strong compatibility, it is suitable for ICUs, respiratory wards, pediatric units, and home care settings.

 

Strengthening Clinical Collaboration for Future Progress

 

Respircare’s booth drew significant attention from experts, scholars, and clinicians. The company’s professional team engaged in in-depth discussions on the latest advancements and clinical needs in respiratory therapy. Valuable feedback from frontline medical professionals further refined Respircare’s future R&D direction.

 

 

The General Manager of Respircare stated: “We remain committed to clinical demand-driven innovation. The products showcased here embody years of R&D achievements, and we will continue to invest in innovation to advance critical care medicine.”

 

 

About Respircare

 

Respircare is a leading domestic manufacturer of respiratory therapy equipment, specializing in technological innovation for critical respiratory support. Its products are widely used in medical institutions nationwide, delivering high-quality respiratory care to countless patients.

 

 

Moving forward, Respircare will uphold its philosophy of “Innovation-Driven Development,” collaborating with healthcare professionals to advance respiratory therapy technology in China.

Return